Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.
Journal: Future oncology (London, England)
Published: May 16, 2026
Upper tract urothelial carcinoma associated with Lynch syndrome.
Journal: Current opinion in oncology
Published: April 01, 2026
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.
Journal: European urology
Published: February 20, 2026
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Journal: CA: a cancer journal for clinicians
Published: September 15, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 11, 2025
Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2025
HER2 and urothelial carcinoma: current understanding and future directions.
Journal: Nature reviews. Urology
Published: July 18, 2025
Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: July 02, 2025
A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) - design and rationale.
Journal: Future oncology (London, England)
Published: June 23, 2025
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 19, 2025
E-VIRTUE: a study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors-design and rationale.
Journal: Future oncology (London, England)
Published: May 27, 2025
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.
Journal: European urology
Published: April 22, 2025
Last Updated: 09/26/2026